These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 1588269
21. Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study. Ojala JP, Helve E, Tikkanen MJ. Cardiology; 1990; 77 Suppl 4():39-49. PubMed ID: 2073671 [Abstract] [Full Text] [Related]
22. Cumulative non-HDL-cholesterol burden in patients with hypertriglyceridemia receiving long-term fibrate therapy: Real life data from a lipid clinic cohort. Kayıkçıoğlu M, Shahbazova S, İbrahimov F, Can LH. Turk Kardiyol Dern Ars; 2020 Jun; 48(4):359-367. PubMed ID: 32519982 [Abstract] [Full Text] [Related]
23. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels. McKenney JM, Barnett MD, Wright JT, Proctor JP. Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045 [Abstract] [Full Text] [Related]
24. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A. Adv Perit Dial; 1996 Sep; 12():261-5. PubMed ID: 8865916 [Abstract] [Full Text] [Related]
28. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study. Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J, CAP Investigators. Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589 [Abstract] [Full Text] [Related]
29. Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients. Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT. Eur J Clin Invest; 2001 Aug; 31(8):707-13. PubMed ID: 11473572 [Abstract] [Full Text] [Related]
31. Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia. Betteridge DJ, Durrington PN, Fairhurst GJ, Jackson G, McEwan MS, McInnes GT, Miller JP, Mir MA, Reckless JP, Rees-Jones DI. Am J Med; 1994 Jun 06; 96(6A):45S-54S. PubMed ID: 8017467 [Abstract] [Full Text] [Related]
32. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V. Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028 [Abstract] [Full Text] [Related]
34. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ. Metabolism; 2001 Jun 24; 50(6):729-33. PubMed ID: 11398153 [Abstract] [Full Text] [Related]
35. Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers. Koskinen P, Kovanen PT, Tuomilehto J, Manninen V. Arch Intern Med; 1992 Jan 24; 152(1):90-6. PubMed ID: 1728934 [Abstract] [Full Text] [Related]
36. Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention? Rizos E, Mikhailidis DP. Cardiovasc Res; 2001 Nov 24; 52(2):199-207. PubMed ID: 11684067 [Abstract] [Full Text] [Related]